Tag: combination
US FDA grants Breakthrough Therapy Designation for combination immunotherapy in HCC...
Roche has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab)...
